FDA Clearance Tracker · P930039-S130
CAPSUREFIX NOVUS MRI SURESCAN LEAD MODEL 5076
Last checked: Nov 20, 2026Latest source record: Jun 22, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jun 22, 2015
Approved
Time to decision
63 days
Received Apr 20, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P930039-S130
- Device name
- CAPSUREFIX NOVUS MRI SURESCAN LEAD MODEL 5076
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Apr 20, 2015
- Decided
- Jun 22, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P930039
Device type
- Device type
- Permanent defibrillator electrodes (NVY)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE USE OF THE CAPSUREFIX NOVUS MRI SURESCAN LEAD MODEL 5076 MRI WITH THE ADVISA SR MRI A3SR01 IMPLANTABLE PULSE GENERATOR.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.